Conference Coverage Intelligence of Asthma and COPD assets across the Respiratory Therapy area

Scope & Objective:

A mid-sized European Pharmaceutical Company, wanted DelveInsight to support them by providing a detailed ATS 2022 conference coverage of the assets of their interest in the Asthma and COPD disease area, including the emerging product analysis, developmental activities, safety and efficacy data, product milestones, future plans and KOL insights.

Congress Coverage Support:

• DelveInsight supported the client by creating a focused conference coverage plan in order to gain in-depth assessment of the Asthma & COPD drugs of their interest.
• In addition to this DelveInsight also conducted primary research in order to cater the KOL and Stakeholder insights around the emerging drugs
• High-priority sessions were selected for more focused live coverage

Congress Plan:

• The team extracted and classified sessions by priorities
• Captured detail presentation and understand the business insights
• KITs and KIQs were aligned with the client’s strategic needs

Outcome:

• The deliverables enabled the client with the proactive response to competitor activities in the Asthma & COPD disease area, and also in the ATS 2022
• Senior internal stakeholders were timely informed for the latest business updates